Simplify Asset Management’s Kyverna Therapeutics KYTX Stock Holding History

Simplify Asset Management’s Portfolio KYTX Stock Details KYTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.63M	Buy	182,603 +9,497	+5%	+$84.3K	0.02%	66
2026 Q1	$1.49M	Sell	173,106 -19,233	-10%	-$160K	0.02%	64
2025 Q4	$1.81M	Buy	+192,339	New	+$1.43M	0.03%	67

Other funds holding KYTX

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Simplify Asset Management's KYTX Position: Q2 2026 in Review

Simplify Asset Management increased its Kyverna Therapeutics (KYTX) stake by 5.5% in Q2 2026, buying an estimated $84.3K and bringing the position to 182,603 shares worth $1.63M. The position accounts for 0.02% of the portfolio, ranked #66.

Simplify Asset Management first reported a position in KYTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.81M in Q4 2025. 2 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

Simplify Asset Management held 182,603 shares of Kyverna Therapeutics worth $1.63M as of Q2 2026.
Simplify Asset Management bought 9,497 Kyverna Therapeutics shares in Q2 2026, an estimated $84.3K.
Kyverna Therapeutics made up 0.02% of Simplify Asset Management's portfolio in Q2 2026, its #66 holding.
Simplify Asset Management first reported a position in Kyverna Therapeutics in Q4 2025 and has held it in 3 quarters since.
Simplify Asset Management's Kyverna Therapeutics position peaked at $1.81M in Q4 2025.
2 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.